logo
Wall Street futures down as Trump's tariffs stay put after latest court ruling

Wall Street futures down as Trump's tariffs stay put after latest court ruling

Yahoo3 days ago

(Reuters) -Wall Street futures slipped on Friday, as investors took stock of an appeals court decision to undo a prior ruling that had blocked most of U.S. President Donald Trump's tariffs, heading into the last trading day of a solid month for equities.
The S&P 500 and the Nasdaq are on pace for their best monthly showing since November 2023, while the Dow is also set for a near 4% monthly advance.
Stocks have seen immense volatility this month on Trump's on-and-off tariff moves, though the S&P 500 has rebounded from its April low and now sits about 4% lower from its all-time high hit in February.
U.S. equities had initially rallied on Thursday when the Court of International Trade ruled late on Wednesday to effectively block most levies imposed since January, but did not address some industry-specific tariffs.
However, a federal appeals court on Thursday temporarily reinstated most of the tariffs and ordered the plaintiffs in the cases to respond by June 5 and the administration by June 9.
"This week's courtroom drama has added another layer of uncertainty to what was already an unsettling series of events," Richard Hunter, head of markets at interactive investor, said in a morning note.
Hopes of more trade deals between the U.S. and major trading partners, along with upbeat earnings and tame inflation data, have been some of the main drivers of gains in equities this month.
U.S. Treasury Secretary Scott Bessent stated that U.S. trade talks with China are "a bit stalled" and getting a deal over the finish line will likely need the direct involvement of President Trump and Chinese President Xi Jinping.
At 5:14 a.m. ET, Dow E-minis were down 31 points, or 0.07%, S&P 500 E-minis were down 8.5 points, or 0.14% and Nasdaq 100 E-minis were down 36.5 points, or 0.17%.
Most megacap and growth stocks inched lower in premarket trading, with Nvidia off 0.7% after gaining in the last session on reporting robust quarterly revenue growth.
Chipmaker Marvell Technology shed 3.9% despite forecasting second-quarter revenue above estimates.
Ulta Beauty gained 8.6% after the cosmetics retailer raised its annual profit forecast after beating quarterly results.
Zscaler advanced 3.2% as the cloud security firm raised its annual profit and revenue forecasts and named Kevin Rubin as its chief financial officer.
Later in the day, the Personal Consumption Expenditure data - the Fed's favored inflation indicator - is scheduled for release at 8:30 a.m. ET, which could shed more light on the U.S. Federal Reserve's interest rate trajectory.
Trump called Fed Chair Jerome Powell to the White House late on Thursday for their first face-to-face meeting since he took office in January and told the central bank chief he was making a "mistake" by not lowering interest rates.
Traders currently see at least two 25 basis points of cuts by the end of the year, according to data compiled by LSEG.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tesla Sales Plunge 67% to an Almost Three-Year Low in France
Tesla Sales Plunge 67% to an Almost Three-Year Low in France

Yahoo

time16 minutes ago

  • Yahoo

Tesla Sales Plunge 67% to an Almost Three-Year Low in France

(Bloomberg) -- Tesla Inc.'s new-vehicle registrations fell further in France, undercutting Chief Executive Officer Elon Musk's assertion last month that the carmaker has recovered from its early-year sales slump. Billionaire Steve Cohen Wants NY to Expand Taxpayer-Backed Ferry Where the Wild Children's Museums Are Now With Colorful Blocks, Tirana's Pyramid Represents a Changing Albania The Economic Benefits of Paying Workers to Move NYC Congestion Toll Brings In $216 Million in First Four Months The automaker sold only 721 cars in May, down 67% from a year earlier, according to French industry association Plateforme Automobile. Tesla's registrations were the lowest since July 2022, despite the company rolling out a redesigned version of its most popular vehicle, the Model Y. Tesla shares dropped as much as 2.3% before the start of regular trading Monday. The stock has declined 14% this year. Musk recently denied the need for a plan to improve Tesla's fortunes, telling Bloomberg News in a May 20 interview that the company had 'already turned around.' While the CEO claimed Tesla was seeing sales decline along with every other carmaker in Europe, manufacturers including Volkswagen AG, Renault SA and BMW AG increased deliveries in the first four months of the year. Tesla's sales have fallen 47% through May in the second-biggest market for electric vehicles in the European Union. The Federal Motor Transport Authority in Germany, the EU's largest EV market, is scheduled to release May figures on June 6. YouTube Is Swallowing TV Whole, and It's Coming for the Sitcom Millions of Americans Are Obsessed With This Japanese Barbecue Sauce Mark Zuckerberg Loves MAGA Now. Will MAGA Ever Love Him Back? Will Small Business Owners Knock Down Trump's Mighty Tariffs? Trump Considers Deporting Migrants to Rwanda After the UK Decides Not To ©2025 Bloomberg L.P.

What's Ahead For The President's Reconciliation Bill
What's Ahead For The President's Reconciliation Bill

Fox News

time16 minutes ago

  • Fox News

What's Ahead For The President's Reconciliation Bill

The House of Representatives' budget reconciliation plan, backed by President Trump, is headed to the Senate. The bill touched on nearly every aspect of President Trump's agenda, which Senate Leader John Thune hopes to have passed by July 4, 2025. The budget bill passed through the House with a slim majority, which concerns some Americans that it may face restraint in the Senate. U.S. Senator Katie Britt (R-AL) joins the Rundown to discuss the Senate's work on President Trump's reconciliation bill and Republicans' efforts to cut taxes, reduce spending, and create more U.S. jobs. She also describes her own bipartisan bill, which aims to improve childcare affordability and help parents re-enter the workforce. Not many people can say they've climbed to the top of Mount Everest, but FOX News Correspondent Mike Tobin can. Making it to the top is extremely dangerous and requires peak physical abilities. Mike joins the podcast to discuss the accomplishment, why he decided to climb Mount Everest, and what it was like to reach the top. Plus, commentary from Chief National Initiatives Officer at the Texas Public Policy Foundation, Chuck DeVore. Learn more about your ad choices. Visit

FTSE pharma giant joins London stock market exodus
FTSE pharma giant joins London stock market exodus

Yahoo

time19 minutes ago

  • Yahoo

FTSE pharma giant joins London stock market exodus

A £1.1bn drug company is to quit the London Stock Exchange (LSE) as the troubled market battles an exodus of businesses. Indivior, which makes opioid addiction treatments, has announced plans to delist in London and focus solely on New York. The company said the move reflected the fact that most of its investors and business were in the US, adding that the depth of the market on Wall Street 'far outweighs' London. It is a fresh blow for the London Stock Exchange, which has been battling to stop an exodus of businesses either to the US or into private hands. The market has also struggled to attract new listings to replace those that have left, leaving it shrinking. In total, 88 companies left the London Stock Exchange last year in the biggest flight from the UK's main market since the financial crash. More broadly, the number of companies listed on the London Stock Exchange has fallen by 40pc since 2008. Indivior was spun out of Reckitt Benckiser, the British consumer goods giant known for Dettol and Durex, in 2014. A member of the FTSE 250, Indivior is best known for its drug Suboxone, which is used to treat addiction to opioids such as heroin. The company said 80pc of its sales now come from America, reflecting both the size of the market and the legacy of the opioid crisis that has ravaged the US. The drug company has been listed on the London stock market since its demerger but acquired a secondary listing on New York's Nasdaq exchange in 2023. New York became its primary listing a year ago. David Wheadon, Indivior's chairman, said: 'A single primary listing on Nasdaq best reflects the profile of Indivior's business.' Over 70pc of its shareholders are now based in the US and 75pc of trades in its shares are carried out on the Nasdaq exchange, the company said. It added: '[The delisting] recognises that liquidity on Nasdaq now far outweighs liquidity on the LSE.' The company said the exit would help it cut costs by ending the complexity of maintaining two listings. The shift follows an overhaul of Invidior's top management in February following pressure from activist investor Oaktree Capital Management. Oaktree accused the company's management of 'doubling down on a failing strategy, ignoring competitive threats and allowing costs to spiral'. Dozens of businesses have moved their listings from London to New York in recent years, including gambling giant Flutter and construction equipment business Ashtead. Travel giant Tui separately quit the London markets to pursue a sole listing in Germany. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store